Home/Filings/4/0001127602-22-026463
4//SEC Filing

PENDARVIS DAVID 4

Accession 0001127602-22-026463

CIK 0000943819other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 1:58 PM ET

Size

8.2 KB

Accession

0001127602-22-026463

Insider Transaction Report

Form 4
Period: 2022-11-25
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
  • Gift

    ResMed Common Stock

    2022-11-287,300100,172 total
  • Exercise/Conversion

    ResMed Common Stock

    2022-11-25$146.34/sh+683$99,950107,472 total
  • Exercise/Conversion

    ResMed Common Stock Options

    2022-11-2568312,540 total
    Exercise: $146.34From: 2020-11-11Exp: 2026-11-21ResMed Common Stock (683 underlying)
Footnotes (2)
  • [F1]Gift of shares to The San Diego Foundation, a 501(c)(3) nonprofit organization. Mr. Pendarvis has no beneficial interest, control or dispositive power over the gifted shares.
  • [F2]Represents date options first became exercisable. Options vest 1/3 per year.

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1
  • filerCIK 0001196723

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 1:58 PM ET
Size
8.2 KB